Genetic architecture of heart failure with preserved versus reduced ejection fraction

Pharmacologic clinical trials for heart failure with preserved ejection fraction have been largely unsuccessful as compared to those for heart failure with reduced ejection fraction. Whether differences in the genetic underpinnings of these major heart failure subtypes may provide insights into the...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Jacob, Liu, Chang, Hui, Qin, Aragam, Krishna, Wang, Zeyuan, Charest, Brian, Huffman, Jennifer E., Keaton, Jacob M., Edwards, Todd L., Demissie, Serkalem, Djousse, Luc, Casas, Juan P., Gaziano, J. Michael, Cho, Kelly, Wilson, Peter W. F., Phillips, Lawrence S., O’Donnell, Christopher J., Sun, Yan V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751124/
https://www.ncbi.nlm.nih.gov/pubmed/36517512
http://dx.doi.org/10.1038/s41467-022-35323-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751124/
https://www.ncbi.nlm.nih.gov/pubmed/36517512
http://dx.doi.org/10.1038/s41467-022-35323-0

Ejemplares similares